The 23andMe Bankruptcy: What It Means for Your Data

23andMe Holding Co. filed for Chapter 11 bankruptcy protection on March 23, 2025 in the U.S. Bankruptcy Court for the Eastern District of Missouri. The consumer service kept running through the filing, but the company’s genetic data and core operating assets entered a court-supervised sale process that has reshaped how that data is owned and governed.

Timeline

The bankruptcy did not arrive without warning. We have followed three earlier signals since 2023.

October 2023: 23andMe disclosed a credential-stuffing attack that ultimately affected roughly 6.9 million users, including approximately 5.5 million DNA Relatives profiles and 1.4 million Family Tree profiles. The incident triggered a wave of class action litigation and meaningful customer churn.

September 2024: most of the independent directors on the 23andMe board resigned at once, citing disagreements over strategic direction. The departures focused investor attention on the company’s path to profitability and on the future of the consumer testing business.

Late 2024 and early 2025: revenue continued to decline as the consumer DNA testing market contracted. An earlier take-private bid from co-founder and CEO Anne Wojcicki did not close.

March 23, 2025: 23andMe Holding Co. filed Chapter 11. The filing included a debtor-in-possession financing package and a plan to pursue a sale of the business and its assets, including genetic data, under bankruptcy court supervision.

What it means for your data

Chapter 11 is reorganization, not liquidation, and it is not the same as a data breach. The filing did not by itself release any user data. Customer accounts remained operable, kits in the lab continued to be processed, and the consumer website stayed live.

What the bankruptcy did do is make explicit what was always true: a customer’s genetic data sits on the company’s balance sheet as an asset. In Chapter 11, that asset is part of the estate and can be sold. The 2025 sale process and the eventual transfer to TTAM Research Institute are covered separately in 23andMe data sale to TTAM, explained. The key point at the bankruptcy stage is procedural. Any sale of the data needed bankruptcy court approval, and that approval process is where consumer consent questions and any conditions on the buyer were litigated.

Worth flagging plainly: the 2023 credential-stuffing incident and the 2025 bankruptcy are different events with different causes. We cover the breach separately in the 23andMe data breach settlement, explained.

What you can do

If you tested with 23andMe and you want to act, there are two concrete steps under your direct control as of early 2026, both free.

You can download your raw DNA data and keep a local copy. That file is yours regardless of what happens to any single company.

You can delete your 23andMe account and request sample destruction. Deletion of the account and destruction of the stored biological sample are two separate requests and skipping one leaves data behind.

If you are weighing whether to test at all in the current environment, our overview of whether it is safe to do a DNA test in 2026 walks through the trade-offs without telling you the answer.

For the broader context on what changed when the data moved to a new owner, see the genetic data privacy hub and our companion piece on who owns your DNA after a test.